Centre for Cancer Biomarkers CCBIO

Centre for Cancer Biomarkers (CCBIO) is a Centre of Excellence at the Faculty of Medicine, University of Bergen. 

The center is working on new cancer biomarkers and targeted therapy, and has particular focus on mechanisms that show how cancer cells are affected by the microenvironment in the tumors, and what significance this has for cancer proliferation and poor prognosis. Centre Director is Lars A. Akslen, Department of Clinical Medicine. Read about our research and activities in the CCBIO Annual Report.

Project managers
CCBIO has eight principal investigators:


Cancer Crosslinks for the 10th time

This year, Cancer Crosslink was organized for the 10th time, and top-notch international speakers attended the meeting entitled “Precision Treatment: Exploiting Recent Advances – Fast and Furious?”. CCBIO postdoc and gynecologist Liv Cecilie Vestrheim Thomsen chaired the meeting together with...


An old drug may prevent cancer

A new study performed at UiB shows that the blood-thinning drug warfarin may prevent the development of cancer


Tapeworm drug fights Prostate Cancer

Medicine against parasites like Tapeworms and Giardia, contains a substance that kills Prostate- and colon cancer.

The Norwegian Cancer Society's 2017-grants

Support from the Cancer Society to three of CCBIO's research projects

The Norwegian Cancer Society has recently announced their 2017-funding. The University of Bergen and Haukeland University Hospital receive 54,7 million NOK, of which 23,2 million go to CCBIO projects.


Oral pathology collaboration project with Eurasia

UiB/CCBIO's Bergen Oral Cancer Research Group and Experimental Pathology Research Group received in 2016 3 million NOK in funding from SIU through the Eurasia program, to a collaboration project for education and research in oral pathology between Norway, Moldova, Belarus and Armenia. The...

Shortcuts: Read CCBIO's Annual Reports and the CCBIO Newsletter

CCBIO is established in 2013 by the Research Council of Norway in collaboration with the University of Bergen. Other important sources of financial support are Helse Vest and the Norwegian Cancer Society. CCBIO is part of the Research Council of Norway's Centres of Excellence (CoE) scheme. The scheme organizes the activities of Norway’s foremost scientific circles in centres to achieve ambitious scientific objectives through collaboration and long-term basic funding.